| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3979132 | Bulletin du Cancer | 2010 | 6 Pages |
Abstract
The fact that vascular endothelial growth factor expression is common in more than 80% of colorectal cancers, lead to recommend the systematic use of bevacizumab with chemotherapy in the treatment of advanced colorectal cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Oukkal, K. Djilat, R.M. Hadjam, M.T. Mahgoun, K. Bentabak, A. Graba, N. Smail, N. Ait Kaci, R. Baba Ahmed, K. Bouzid,